From market darling to huge valuation multiple drops
Great stuff. What can investors look at now to see who is taking the “medicine”? Are there certain metrics you would recommend a non-finance guy (me) should look at in a 10-K, etc?
Great stuff. What can investors look at now to see who is taking the “medicine”? Are there certain metrics you would recommend a non-finance guy (me) should look at in a 10-K, etc?